CMS doubles the number of drugs subject to inflation remedies
The Biden administration identified 43 drugs subject to rebates from manufacturers to Medicare and lower coinsurance rates for beneficiaries starting July 1 -- more than double the current number. Host Kelly Hooper talks with Robert King about the Centers for Medicare and Medicaid Services' decision.
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The Biden administration identified 43 drugs subject to rebates from manufacturers to Medicare and lower coinsurance rates for beneficiaries starting July 1 -- more than double the current number. Host Kelly Hooper talks with Robert King about the Centers for Medicare and Medicaid Services' decision.
Learn more about your ad choices. Visit megaphone.fm/adchoices